b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">30587986</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>02</Month>\n            <Day>04</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Electronic">1178-2013</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>14</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of nanomedicine</Title>\n                <ISOAbbreviation>Int J Nanomedicine</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>75-85</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.2147/IJN.S187906</ELocationID>\n            <Abstract>\n                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Many novel drug delivery systems have been extensively studied to exploit the full therapeutic potential of SN38, which is one of the most potent antitumor analogs of camptothecins (CPTs), whose clinical application is seriously hindered by poor water solubility, low plasmatic stability, and severe toxicity, but results are always unsatisfactory.</AbstractText>\n                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">In this study, combining the advantages of prodrug and nanotechnology, a lipophilic prodrug of SN38, SN38-PA, was developed by conjugating palmitic acid to SN38 via ester bond at C<sub>10</sub> position, and then the lipophilic prodrug was encapsulated into a long-circulating liposomal carrier by film dispersion method.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The SN38-PA liposomes were characterized as follows: an average particle size of 80.13 nm, an average zeta potential of -33.53 mv, and the entrapment efficiency of 99%. Compared with CPT-11, SN38-PA liposome was more stable in close lactone form, more efficient in conversion rate to SN38, and more potent in cytotoxicity against tumor cells. Pharmacokinetic study showed that SN38-PA liposome had significantly enhanced plasma half-life (t<sub>1/2</sub>) value of SN38 and increased area under the curve (AUC) of SN38, which was 7.5-fold higher than that of CPT-11. Biodistribution study showed that SN38-PA liposome had more active metabolite SN38 in each tissue. Finally, the pharmacodynamic study showed that SN38-PA liposome had higher antitumor effect with the antitumor inhibition rate of 1.61 times than that of CPT-11.</AbstractText>\n                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">These encouraging data merit further investigation on this novel SN38-PA liposome.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Wu</LastName>\n                    <ForeName>Chan</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, People\'s Republic of China, yjcjm@163.com; lilideng2004@126.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Yang</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, People\'s Republic of China, yjcjm@163.com; lilideng2004@126.com.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, Shanghai Tenth People\'s Hospital, School of Medicine, Tongji University, Shanghai 200072, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yang</LastName>\n                    <ForeName>Daoqiu</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, 107th Hospital of PLA, Yantai 264000, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Jinfeng</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Traditional Chinese Medicine, Shanghai Hospital of Chinese Integrative Medicine, Shanghai, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ma</LastName>\n                    <ForeName>Juanjuan</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, People\'s Republic of China, yjcjm@163.com; lilideng2004@126.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cheng</LastName>\n                    <ForeName>Dan</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, People\'s Republic of China, yjcjm@163.com; lilideng2004@126.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chen</LastName>\n                    <ForeName>Jianming</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, People\'s Republic of China, yjcjm@163.com; lilideng2004@126.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Deng</LastName>\n                    <ForeName>Li</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, People\'s Republic of China, yjcjm@163.com; lilideng2004@126.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>20</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>New Zealand</Country>\n            <MedlineTA>Int J Nanomedicine</MedlineTA>\n            <NlmUniqueID>101263847</NlmUniqueID>\n            <ISSNLinking>1176-9114</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008081">Liposomes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011355">Prodrugs</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>059QF0KO0R</RegistryNumber>\n                <NameOfSubstance UI="D014867">Water</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>7673326042</RegistryNumber>\n                <NameOfSubstance UI="D000077146">Irinotecan</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>NV1779205D</RegistryNumber>\n                <NameOfSubstance UI="D020003">1-Octanol</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D020003" MajorTopicYN="N">1-Octanol</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016503" MajorTopicYN="N">Drug Delivery Systems</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077146" MajorTopicYN="N">Irinotecan</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011355" MajorTopicYN="N">Prodrugs</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055672" MajorTopicYN="N">Static Electricity</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014867" MajorTopicYN="N">Water</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">CPT-11</Keyword>\n            <Keyword MajorTopicYN="N">SN38</Keyword>\n            <Keyword MajorTopicYN="N">biodistribution</Keyword>\n            <Keyword MajorTopicYN="N">lipophilic prodrug</Keyword>\n            <Keyword MajorTopicYN="N">long-circulating liposome</Keyword>\n            <Keyword MajorTopicYN="N">pharmacodynamics</Keyword>\n            <Keyword MajorTopicYN="N">pharmacokinetics</Keyword>\n        </KeywordList>\n        <CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30587986</ArticleId>\n            <ArticleId IdType="doi">10.2147/IJN.S187906</ArticleId>\n            <ArticleId IdType="pii">ijn-14-075</ArticleId>\n            <ArticleId IdType="pmc">PMC6304248</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2000 Apr;28(4):423-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10725311</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2000 Aug;11(8):1029-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11038041</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res. 2002;4(3):95-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12052251</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Chemother Pharmacol. 2005 Mar;55(3):263-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15592838</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Pharm. 2005 Jul 14;298(1):198-205</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15951143</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Control Release. 2005 Nov 28;108(2-3):453-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16182400</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 1991 Aug 15;51(16):4187-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1651156</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Bioconjug Chem. 2008 Apr;19(4):849-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18370417</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Pharm. 2009 Jan 5;365(1-2):170-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18778761</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest New Drugs. 2012 Feb;30(1):290-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20857171</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Adv Drug Deliv Rev. 2013 Jan;65(1):36-48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23036225</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Control Release. 2013 Aug 10;169(3):329-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23246468</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Control Release. 2013 Mar 10;166(2):147-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23266448</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Control Release. 2013 Nov 28;172(1):48-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23928356</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Pharm. 2013 Nov 1;456(1):175-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23933439</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomaterials. 2013 Nov;34(34):8756-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23937913</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Pharm. 2014 Aug 25;471(1-2):485-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24879937</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2015 May 1;360(2):205-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25684664</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomaterials. 2015 May;51:22-29</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25770994</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomaterials. 2015 Sep;62:176-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26057133</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Opin Drug Deliv. 2015;12(12):1911-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26206312</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomaterials. 2016 Feb;79:69-78</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26695118</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Nanomedicine. 2016 Apr 26;11:1677-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27217746</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Pharm. 2016 Oct 15;512(1):39-48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27544846</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Control Release. 2017 Jul 10;257:76-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27677603</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Control Release. 2017 Feb 10;247:28-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28027948</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Molecules. 2018 Apr 14;23(4):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29662019</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharm Biopharm. 2018 Jul;128:188-199</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29678733</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'